EDUCATING LEADERS IN PHARMACY AND PHARMACEUTICAL SCIENCES SINCE 1886
David M. Jacobs PharmD, PhD
David M. Jacobs
PharmD, PhD
Professional Summary:
The focus and application of my research program is centered on the intersection of pharmaceutical health services, pharmacoepidemiology, and implementation science. My research approach emphasizes multi-disciplinary and collaborative research strategies encompassing interventional, observational, and mixed methods across a variety of therapeutic areas. Specifically, my current research has three main areas of focus:
1) use of large data sets, data mining techniques, and comparative effectiveness research to predict and evaluate outcomes of acute and chronic medications,
2) implementation and evaluation of pharmacist care services to improve patient safety and care quality,
3) optimizing chronic disease management and treatment adherence through cost-effective approaches.
Member of Team Alice, an interprofessional initiative to protect older adults from medication related harm.
Education and Training:
- PhD, Epidemiology, University at Buffalo School of Public Health and Health Professions (2018)
- Fellowship, Clinical Pharmacokinetics Laboratory (2014)
- PGY-2 Infectious Diseases Residency, Universtiy of Houston College of Pharmacy (2013)
- PGY-1 Pharmacy Practice Residency, University of Toledo Medical Center (2012)
- PharmD, Pharmacy, University at Buffalo School of Pharmacy and Pharmaceutical Sciences (2011)
- BS, Chemistry, Binghamton University (2007)
Employment:
- Assistant Professor, Pharmacy Practice, University at Buffalo, School of Pharmacy (2018-present)
- Clinical Assistant Professor, Pharmacy Practice, University at Buffalo, School of Pharmacy (2014–2018)
Awards and Honors:
- Saxon Graham Award for Academic Excellence in Epidemiology, School of Public Health and Health Professions, University at Buffalo (2019)
- Faculty Research Award, Department of Pharmacy Practice, UB School of Pharmacy and Pharmaceutical Sciences (2019)
- Presentation Merit Award Semifinalist, Annual Meeting of the American Pharmacists Association (2019)
- Best Research Poster Award Finalist, 24th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (2019)
- Holger Schunemann Award for Graduate Student Research, Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo (2018)
- Delta Omega Honorary Society in Public Health, University at Buffalo (2018)
- Best Poster Finalist, 22nd Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (2017)
- Infectious Diseases Society of America Travel Grant (2016)
- Who's Who Among Students in American Universities and Colleges (2015)
- International Society of Pharmacoeconomics and Outcomes Research Travel Grant (2015)
- Infectious Diseases Society of America Fellow Travel Grant (2014)
- Making a Difference in Infectious Disease Pharmacotherapy (MAD-ID) Resident Travel Grant (2013)
- Shining Star Award, University of Toledo (2011)
- Mylan Pharmaceutical Inc., Excellence in Pharmacy Award (2011)
- American Assoication of Colleges of Pharmacy - Wal Mart Scholarship (2010)
Grants and Sponsored Research:
- March 2023–February 2024
A Pilot Pharmacist-to-pharmacist Hand-off Intervention During Transitions of Care
American Association of Colleges of Pharmacy
Role: Co-Investigator
$7,500 - August 2020–July 2021
Planning for NIA R21/R33 Grant- Patient Driven Deprescribing to Enhance Successful Aging
US Deprescribing Research Network
Role: Co-Investigator
$60,000 - July 2020–June 2021
Comparison of triple therapy with apixaban vs. rivaroxabn
American College of Clinical Pharmacy Cardiology PRN
Role: Co-Investigator - July 2019–June 2021
Implementation Research to Improve Medication Management in COPD
NIH/National Heart, Lung, and Blood Institute Loan Repayment Award, Clinical Research
Role: Principal Investigator - July 2019–June 2021
Impact of an integrated pharmacist and primary care collaborative transitions of care program on clinical and economic outcomes among high risk patients
ASHP Foundation
Role: Principal Investigator
$77,618 - May 2019–April 2021
Development and implementation of a chronic obstructive pulmonary disease care transition intervention integrating pharmacists onto the care team.
NIH/National Heart, Lung, and Blood Institute (1K12HL138052-01)
Role: Principal Investigator - May 2019–April 2021
Community-Based Participatory Research for Reducing Medication Harm among Retirees
Retirement Research Foundation
Role: Co-Investigator
$200,000 - January 2020–January 2021
Impact and feasibility of establishing a community health worker program within community pharmacy settings
Community Pharmacy Foundation
Role: Principal Investigator - August 2019–July 2020
The Deprescribing Network of Western New York for Successful Aging
UB Seeds for Innovation in Successful Aging
Role: Co-Investigator
$30,000 - July 2018–June 2020
Pain medication prescription following treatment for alcohol use disorder
National Institute on Alcoholism and Alcohol Abuse
Role: Co-Investigator
$386,013 - September 2017–September 2019
Optimizing Pain Management and Opioid Safety: A Community Pharmacy Intervention to Prevent Opioid Adverse Drug Events
Centers for Medicare and Medicaid Services
Role: Co-Investigator - July 2017–June 2019
Clinical Epidemiology in Chronic Obstructive Pulmonary Disease
NIH/National Heart, Lung, and Blood Institute Loan Repayment Award, Clinical Research
Role: Principal Investigator - February 2018–April 2019
A Pilot Study to Evaluate Objective Assessment Tools to Improve Medication Management in Chronic Obstructive Pulmonary Disease
Buffalo Translational Consortium Mentored Career Development Award
Role: Principal Investigator - February 2017–June 2018
Proton pump Inhibitors and the Risk of Acute Kidney Disease and Chronic Kidney Disease in a Medicaid Population
University at Buffalo School of Pharmacy and Pharmaceutical Sciences Seed Grant
Role: Principal Investigator - July 2015–June 2017
Multi-Center Characterization of the Treatment of Candiduria
Astellas Pharmaceuticals Investigator Initiated Research
Role: Principal Investigator - January 2016–December 2016
Development of a Clinical Risk Score to Identify 30-day Rehospitalization among Patients on Outpatient Intravenous Antibiotic Therapy
Research for Health in Erie County, Inc.
Role: Principal Investigator
Journal Articles:
- Murray F, Allen M, Clark CM, Daly CJ, Jacobs DM. Socio-demographic and -economic factors associated with 30-day readmission for conditions targeted by the hospital readmissions reduction program: a population-based study. BMC Public Health. 2021; 21(1).
- Daly CJ, Verrall K, Jacobs DM. Impact of Community Pharmacist Interventions With Managed Care to Improve Medication Adherence. J Pharm Pract. 2021; 34(5).
- Foster AA, Daly CJ, Logan T, Logan R, Jarvis H, Croce J, Jalal Z, Trygstad T, Bowers D, Clark B, Moore S, Jacobs DM. Addressing social determinants of health in community pharmacy: Innovative opportunities and practice models. J Am Pharm Assoc (2003). 2021; 61(5).
- Puzanov I, Subramanian P, Yatsynovich YV, Jacobs DM, Chilbert MR, Sharma UC, Ito F, Feuerstein SG, Stefanovic F, Switzer B, Hicar MD, Curtis AB, Spangenthal EJ, Dy GK, Ernstoff MS, Vachhani P, Page BJ, Agrawal N, Khunger A, Kapoor A, Hattoum A, Jerome SJ. Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis. J Immunother Cancer. 2021; 9(6).
- Lu CH, Clark CM, Tober R, Allen M, Gibson W, Bednarczyk EM, Daly CJ, Jacobs DM. Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program. BMC Health Serv Res. 2021; 21(1).
- Shaver AL, Clark CM, Hejna M, Feuerstein S, Wahler RG, Jacobs DM. Trends in Fall-Related Mortality and Fall Risk Increasing Drugs Among Older Individuals in the United States,1999-2017.. Pharmacoepidemiol Drug Saf. 2021.
- Crutchley RD, Jacobs DM, Gathe J, Mayberry C, Bulayeva N, Rosenblatt KP, Garey KW. Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy. Curr HIV Res. 2021; 19(1).
- Daly CJ, Quinn B, Mak A, Jacobs DM. Community Pharmacists' Perceptions of Patient Care Services within an Enhanced Service Network. Pharmacy (Basel). 2020; 8(3).
- Crutchley RD, Jacobs DM, Gathe J, Mayberry C, Bulayeva N, Rosenblatt KP, Garey KW. Assessing changes in vitamin D over 48 weeks in treatment-naïve HIV individuals starting lopinavir/ritonavir monotherapy. Curr HIV Res. 2020.
- Clark CM, Shaver AL, Aurelio LA, Feuerstein S, Wahler RG, Daly CJ, Jacobs DM. Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs. J Am Geriatr Soc. 2020.
- Slazak E, Cardinal C, Will S, Clark CM, Daly CJ, Jacobs DM. Pharmacist-led transitions-of-care services in primary care settings: Opportunities, experiences, and challenges. J Am Pharm Assoc (2003). 2020; 60(3).
- Clark CM, Jacobs DM, Sethi S. Revefenacin for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med. 2020; 14(3).
- Slazak EM, Shaver AL, Clark CM, Cardinal C, Panthapattu M, Prescott WA, Will S, Jacobs DM. Implementation of a pharmacist-led transitions of care program within a primary care practice: a two-phase pilot study. Pharmacy. 2020; 8(1).
- Slazak EM, Cardinal CM, Will S, Clark C, Daly CJ, Jacobs DM. Pharmacist-led transition of care services in primary care settings: opportunities, experiences, and challenges. Journal of the American Pharmacists Association. 2020; 60.
- Jacobs DM, Ochs-Balcom HM, Noyes K, Zhao J, Leung WY, Pu CY, Murphy TF, Sethi S. Impact of Pseudomonas aeruginosa Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort. Open Forum Infect Dis. 2020; 7(1).
- Slazak E, Cardinal C, Will S, Clark CM, Daly CJ, Jacobs DM. Pharmacist-led transitions-of-care services in primary care settings: Opportunities, experiences, and challenges. J Am Pharm Assoc (2003). 2019.
- Clark CM, Jacobs DM, Sethi S. Revefenacin for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med. 2019.
- Daly CJ, Verrall K, Jacobs DM. Impact of Community Pharmacist Interventions With Managed Care to Improve Medication Adherence. J Pharm Pract. 2019.
- Hart E, Nguyen M, Allen M, Clark CM, Jacobs DM. A systematic review of the impact of antifungal stewardship interventions in the United States. Ann Clin Microbiol Antimicrob. 2019; 18(1).
- Shaver AL, Jacobs DM, LaMonte MJ, Noyes K. Antibiotic prescribing for acute respiratory tract infections in the United States outpatient setting. BMC Fam Pract. 2019; 20(1).
- Hart E, Dunn TE, Feuerstein S, Jacobs DM. Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study. Pharmacotherapy. 2019.
- Jacobs DM, Pandit U, Sethi S. Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones? Curr Opin Infect Dis. 2019.
- Dilworth TJ, Casapao AM, Ibrahim OM, Jacobs DM, Bowers DR, Beyda ND, Mercier RC. Adjuvant β-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does β-lactam class matter? Antimicrob Agents Chemother. 2019.
- Hefti E, Jacobs DM, Rana K, Blanco JG. Analysis of outpatient HER2 testing in New York state using the statewide planning and research cooperative system. Pharmacogenomics. 2018.
- Jacobs DM, Ochs-Balcom HM, Zhao J, Murphy TF, Sethi S. Lower Airway Bacterial Colonization Patterns and Species-specific Interactions in Chronic Obstructive Pulmonary Disease. J Clin Microbiol. 2018.
- Jacobs DM, Noyes K, Zhao J, Gibson W, Murphy TF, Sethi S, Ochs-Balcom HM. Early Hospital Readmissions Following an Acute Exacerbation of COPD in the Nationwide Readmissions Database. Ann Am Thorac Soc. 2018.
- Jacobs DM, Leung WY, Essi D, Park W, Shaver A, Claus J, Ruh C, Rao GG. Incidence and risk factors for healthcare utilisation among patients discharged on outpatient parenteral antimicrobial therapy. Epidemiol Infect. 2018; 146(6).
- Jacobs DM, Dilworth TJ, Beyda ND, Casapao AM, Bowers DR. Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study. Antimicrob Agents Chemother. 2018; 62(1).
- Jacobs DM, Noyes K, Zhao J, Gibson W, Murphy TF, Sethi S, Ochs-Balcom HM. Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database. Ann Am Thorac Soc. 2018; 15(7).
- Jacobs DM, Safir MC, Huang D, Minhaj F, Parker A, Rao GG. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review. Ann Clin Microbiol Antimicrob. 2017; 16(1).
- Jacobs DM, Yung F, Hart E, Nguyen MNH, Shaver A. Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States. Vaccine. 2017.
- Casapao AM, Jacobs DM, Bowers DR, Beyda ND, Dilworth TJ. Early administration of adjuvant β-lactam therapy in combination with vancomycin among patients with methicillin-resistant Staphylococcus aureus bloodstream infection: a retrospective, multicenter analysis. Pharmacotherapy. 2017.
- Jacobs DM, Holsen M, Chen S, Fusco NM, Hassinger AB. Procalcitonin to Detect Bacterial Infections in Critically Ill Pediatric Patients. Clin Pediatr (Phila). 2017; 56(9).
- Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ. An integrated epidemiological and neural net model of the warfarin effect in managed care patients. Clin Pharmacol. 2017; 9.
- Dobson EL, Klepser ME, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP, Turner RB, Su CP, Jacobs DM, Suda KJ. Outpatient antibiotic stewardship: Interventions and opportunities. J Am Pharm Assoc (2003). 2017.
- Klepser ME, Dobson EL, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP, Turner RB, Su CP, Jacobs DM, Suda KJ. A call to action for outpatient antibiotic stewardship. J Am Pharm Assoc (2003). 2017.
- Daly CJ, Tierney SL, O‘Brien E, Fiebelkorn KD, Jacobs DM. Career Progression of the Pharmacy/MBA Professional: Characterization and Perceptions of the Combined Degree. Am J Pharm Educ. 2017; 81(4).
- Jacobs DM, Daly CJ, Tierney SL, O‘Brien E, Fiebelkorn KD. Attitudes and Perceptions of Dual PharmD/MBA Degree Program Students. Am J Pharm Educ. 2017; 81(4).
- Jacobs DM, Shaver A. Prevalence of and outcomes from Staphylococcus aureus pneumonia among hospitalized patients in the United States, 2009-2012. Am J Infect Control. 2017; 45(4).
- Diep JK, Jacobs DM, Sharma R, Covelli J, Bowers DR, Russo TA, Rao GG. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2017; 61(2).
- Gubbins PO, Klepser ME, Adams AJ, Jacobs DM, Percival KM, Tallman GB. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases. J Public Health Manag Pract. 2016.
- Jacobs DM, DiTursi S, Ruh C, Sharma R, Claus J, Banjade R, Rao GG. Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient. Int J Antimicrob Agents. 2016; 48(2).
- Abboud CS, Monteiro J, Stryjewski ME, Zandonadi EC, Barbosa V, Dantas D, Sousa EE, Fonseca MJ, Jacobs DM, Pignatari AC, Kiffer C, Rao GG. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics. Int J Antimicrob Agents. 2016; 47(5).
- Caruana JA, Monte SV, Jacobs DM, Voytovich C, Ghanim H, Dandona P. Distal small bowel bypass for weight regain after gastric bypass: safety and efficacy threshold occurs at <70% bypass. Surg Obes Relat Dis. 2015; 11(6).
- Jacobs DM, Beyda ND, Asuphon O, Alam MJ, Garey KW. Host factors and clinical outcomes of Candida colonization in critically ill patients. Mycopathologia. 2015; 179(1-2).
- Paladino JA, Jacobs DM, Shields RK, Taylor J, Bader J, Adelman MH, Wilton GJ, Crane JK, Schentag JJ. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations. Int J Antimicrob Agents. 2014; 44(6).
- Justo JA, Gauthier TP, Scheetz MH, Chahine EB, Bookstaver PB, Gallagher JC, Hermsen ED, DePestel DD, Ernst EJ, Jacobs DM, Esterly JS, Suda KJ, Olsen KM, Abbo LM, MacDougall C. Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials. Clin Infect Dis. 2014; 59 Su.
- Jacobs DM, Kuper K, Septimus E, Arafat R, Garey KW. Assessment of Antimicrobial Stewardship Activities in a Large Metropolitan Area. J Pharm Pract. 2014.
- Hoover MJ, Jung R, Jacobs DM, Peeters MJ. Educational testing validity and reliability in pharmacy and medical education literature. Am J Pharm Educ. 2013; 77(10).
- Bowers DR, Hunter AS, Jacobs DM, Kuper KM, Musick WL, Perez KK, Shah DN, Schilling AN. Significant publications on infectious diseases pharmacotherapy in 2012. Am J Health Syst Pharm. 2013; 70(21).
- Cappelletty D, Jacobs D. Evaluating the impact of a pharmacist‘s absence from an antimicrobial stewardship team. Am J Health Syst Pharm. 2013; 70(12).
- Jacobs DM, Duggan JM, Sahloff EG. Gingival hypertrophy associated with amlogidpine use in a HIV-infected woman. J Pharm Technol. 2013.
Books and Book Chapters:
- Cappelletty DM, Jacobs DM, Klochan SA. "Community-Acquired Pneumonia". 2014.
Abstracts:
- Richbart M, Shah D, Stoll J, Clark CM, Singh R, Wahler RG, Jacobs DM. Association between polypharmacy and patients’ attitudes towards deprescribing. J Am Coll Clin Pharm. 2020.
- Brady L, LaValley S, Ranahan M, Clark CM, Monte SV, Jacobs DM, Wahler RG, Singh R. Provider-Identified Deprescribing Facilitators and Strategies for Older Adults in Primary Care: A Team Alice Study. Innov Aging. 2020; 4.
- Shaver A, Clark CM, Hejna M, Feuerstein SG, Wahler RG, Jacobs DM. Trends in falls risk increasing drugs (FRIDs) and rate of fatal falls in older adults, 1999-2017. J Am Pharm Assoc. 2020.
- Pudim E, Nguyen M, Allen M, Clark CM, Daly CJ, Jacobs DM. Perceptions and Barriers to the Implementation of Antimicrobial Stewardship Services in Community Pharmacy Settings. J Am Coll Clin Pharm. 2020.
- Aurelio LA, Clark CM, Feuerstein SG, Shaver A, Wahler RG, Daly CJ, Jacobs DM. Prevalence and Predictors of Potentially Inappropriate Medication Prescribing among Older Adults in the United States: A Population-based Study. J Am Coll Clin Pharm. 2020.
- Clark CM, Aurelio LA, Feuerstein SG, Shaver A, Wahler RG, Daly CJ, Jacobs DM. Potentially inappropriate medication prescribing is associated with increased healthcare utilization and costs among older adults in the United States. J Am Coll Clin Pharm. 2020.
- Jacobs DM, Holsen M, Chen S, Fusco NM, Hassinger AB. The Utility of Procalcitonin to Support Clinical Decision Making in Critically Ill Pediatric Patients. Open Forum Infectious Diseases. 2016; 3.
- Heiermann, AW, Monte S, Feuerstein, SG, Jacobs DM, Wahler RG. Validation of a Novel Medication Profile Based Falls Risk Assessment Tool. Journal of the American Pharmacists Association. 2016; 56(3).
Professional Memberships:
- Loan Repayment Program Ambassador, Division of Loan Repayment, National Institutes of Health (2018–present)
- International Society of Pharmacoeconomics and Outcomes Research (2016–present)
- Society of Infectious Disease Pharmacists (2012–present)
- American College of Clinical Pharmacy (2011–present)
- American Association of Colleges of Pharmacy (2010–present)
Presentations:
- "A systematic review on the impact of antifungal stewardship interventions in the United States" Annual meeting of the American College of Clinical Pharmacy (2018)
- "Adjuvant β-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does β-lactam class matter." Annual Meeting of the Infectious Diseases Society of America (2018)
- "Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study" Annual meeting of the American College of Clinical Pharmacy (2018)
- "Characterization of candiduria treatment: a multi-institutional study." 57th Interscience Conference on Antimicrobial Agents and Chemotherapy (2017)
- "Risk factors for healthcare utilization among patients discharged on outpatient parenteral antimicrobial therapy." 57th Interscience Conference on Antimicrobial Agents and Chemotherapy (ASM Microbe), (2017)
- "Changing Epidemiology of Pneumococcal Meningitis in the United States, 2008-2013." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research (2017)
- "The utility of procalcitonin to support clinical decision making in critically ill pediatric patients." 54th Annual Meeting of the Infectious Diseases Society of America (2016)
- "Incidence and outcomes of S. aureus pneumonia among hospitalized patients in the United States, 2009 – 2012." International Society of Pharmacoeconomics and Outcomes Research (2016)
- "Early beta-lactam therapy combined with standard therapy for methicillin-resistant S. aureus bloodstream infections compared to standard therapy alone: a multicenter, restrospective, propensity-matched analysis." 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, (2015)
- "Shifts in incidence and mortality of ESKAPE septicemia among US hospitalized patients from 2008-2012" 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (2015)
- "Triple antibiotic combinations for the treatment of carbapenemase-producing Enterobacteriaceae (CPE): an outcomes based systematic review." 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, (2015)
- "Current attitudes and perceptions of dual PharmD/MBA degree program students: a qualitative analysis." Annual meeting of the American Association of Colleges of Pharmacy (2015)
- "Impact of a master of business administration (MBA) degree on the career of a pharmacists." Annual meeting of the American Association of Colleges of Pharmacy (2015)
- "Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with MRSA skin and soft tissue infections." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research, (2015)
- "Evaluation of bleeding outcomes linked to new oral anticoagulants: a review of the FDA adverse event reporting system." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research (2015)
- "Analysis of an enhanced medication letter initiative within a Medicaid retrospective drug utilization program" Annual meeting of the American Pharmacists Association (2015)
- "Effectiveness of a mailed letter intervention to address potentially inappropriate psychiatric medication use with a Medicaid fee-for service population" Annual meeting of the American Pharmacists Association (2015)
- "Antibiotic polytherapy against multidrug-resistant, KPC-2 producing Enterobacter infections: case series and systematic review" Annual meeting of the American College of Clinical Pharmacy (2014)
- "Comparison of weight and metabolic profiles in patients treated with an oral mimetic of the Roux-en-Y gastric bypass effect" Annual meeting of the American Gastroenterological Association at Digestive Disease Week (2014)
- "Host factors for Candida colonization in critically ill patients" 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (2013)